Bridging Genomics and Manufacturing: Middleware Solutions for Personalized Medicine Production
Keywords:
Personalized Medicine Manufacturing, Distributed Middleware Orchestration, Genomic Data Integration, Privacy-Preserving Computation, Digital Twin ArchitectureAbstract
Pharmaceutical companies, faced with stiff competition from the rapid progression of genomic medicineand next-generation sequencing (NGS) technology adoption, are beginning to move from their customary mass manufacturing model to a patient-centric therapeutic model
References
Lyndsey Fletcher, "The $100 Genome: Where’s the Limit?" in Front Line Genomics, 2025. Available: https://frontlinegenomics.com/the-100-genome-wheres-the-limit/


